{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,25]],"date-time":"2026-07-25T05:11:17Z","timestamp":1784956277825,"version":"3.55.0"},"reference-count":25,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2019,9,1]],"date-time":"2019-09-01T00:00:00Z","timestamp":1567296000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2019,9,1]],"date-time":"2019-09-01T00:00:00Z","timestamp":1567296000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/100000049","name":"National Institute on Aging","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000049","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["R01AG034676"],"award-info":[{"award-number":["R01AG034676"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["ajo.com","clinicalkey.fr","clinicalkey.jp","clinicalkey.com.au","clinicalkey.es","clinicalkey.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["American Journal of Ophthalmology"],"published-print":{"date-parts":[[2019,9]]},"DOI":"10.1016\/j.ajo.2019.04.017","type":"journal-article","created":{"date-parts":[[2019,5,9]],"date-time":"2019-05-09T11:35:56Z","timestamp":1557401756000},"page":"99-105","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":103,"special_numbering":"C","title":["Incidence, Epidemiology, and Transformation of Ocular Myasthenia Gravis: A Population-Based Study"],"prefix":"10.1016","volume":"205","author":[{"given":"Tina M.","family":"Hendricks","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M. Tariq","family":"Bhatti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David O.","family":"Hodge","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3644-7528","authenticated-orcid":false,"given":"John J.","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"1","key":"10.1016\/j.ajo.2019.04.017_bib1","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1186\/1471-2377-10-46","article-title":"A systematic review of population based epidemiological studies in myasthenia gravis","volume":"10","author":"Carr","year":"2010","journal-title":"BMC Neurol"},{"issue":"3","key":"10.1016\/j.ajo.2019.04.017_bib2","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1159\/000279334","article-title":"The incidence of myasthenia gravis: a systematic literature review","volume":"34","author":"McGrogan","year":"2010","journal-title":"Neuroepidemiology"},{"issue":"12","key":"10.1016\/j.ajo.2019.04.017_bib3","doi-asserted-by":"crossref","first-page":"2015","DOI":"10.1007\/s00415-010-5651-z","article-title":"Myasthenia gravis: a changing pattern of incidence","volume":"257","author":"Casetta","year":"2010","journal-title":"J Neurol"},{"issue":"2","key":"10.1016\/j.ajo.2019.04.017_bib4","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1002\/mus.20950","article-title":"Lifetime course of myasthenia gravis","volume":"37","author":"Grob","year":"2008","journal-title":"Muscle Nerve"},{"issue":"1","key":"10.1016\/j.ajo.2019.04.017_bib5","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1016\/j.jns.2008.05.023","article-title":"Prognosis of ocular myasthenia in Korea: a retrospective multicenter analysis of 202 patients","volume":"273","author":"Hong","year":"2008","journal-title":"J Neurol Sci"},{"issue":"5","key":"10.1016\/j.ajo.2019.04.017_bib6","doi-asserted-by":"crossref","first-page":"516","DOI":"10.1002\/ana.410140504","article-title":"Prognosis of ocular myasthenia","volume":"14","author":"Bever","year":"1983","journal-title":"Ann Neurol"},{"issue":"6","key":"10.1016\/j.ajo.2019.04.017_bib7","doi-asserted-by":"crossref","first-page":"985","DOI":"10.1001\/archopht.1959.04220060057010","article-title":"Evaluation of ocular signs and symptoms in myasthenia gravis","volume":"62","author":"Schlezinger","year":"1959","journal-title":"AMA Arch Ophthalmol"},{"issue":"12","key":"10.1016\/j.ajo.2019.04.017_bib8","doi-asserted-by":"crossref","first-page":"1202","DOI":"10.1016\/j.mayocp.2012.08.012","article-title":"History of the Rochester Epidemiology Project: half a century of medical records linkage in a US population","volume":"87","author":"Rocca","year":"2012","journal-title":"Mayo Clin Proc"},{"issue":"4","key":"10.1016\/j.ajo.2019.04.017_bib9","doi-asserted-by":"crossref","first-page":"665","DOI":"10.1093\/brain\/123.4.665","article-title":"The incidence and lifetime prevalence of neurological disorders in a prospective community-based study in the UK","volume":"123","author":"MacDonald","year":"2000","journal-title":"Brain"},{"issue":"4","key":"10.1016\/j.ajo.2019.04.017_bib10","doi-asserted-by":"crossref","first-page":"492","DOI":"10.1136\/jnnp.65.4.492","article-title":"Myasthenia gravis: a population based epidemiological study in Cambridgeshire, England","volume":"65","author":"Robertson","year":"1998","journal-title":"J Neurol Neurosurg Psychiatry"},{"issue":"4","key":"10.1016\/j.ajo.2019.04.017_bib11","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1007\/BF01215447","article-title":"Ocular myasthenia gravis. A critical review of clinical and pathophysiological aspects","volume":"84","author":"Sommer","year":"1993","journal-title":"Doc Ophthalmol"},{"issue":"7","key":"10.1016\/j.ajo.2019.04.017_bib12","doi-asserted-by":"crossref","first-page":"1517","DOI":"10.1016\/j.ophtha.2015.03.010","article-title":"Prognosis of ocular myasthenia gravis","volume":"122","author":"Nagia","year":"2015","journal-title":"Ophthalmology"},{"issue":"2","key":"10.1016\/j.ajo.2019.04.017_bib13","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1001\/archneur.60.2.243","article-title":"Development of generalized disease at 2 years in patients with ocular myasthenia gravis","volume":"60","author":"Kupersmith","year":"2003","journal-title":"Arch Neurol"},{"issue":"2","key":"10.1016\/j.ajo.2019.04.017_bib14","doi-asserted-by":"crossref","first-page":"156","DOI":"10.1136\/jnnp.62.2.156","article-title":"Ocular myasthenia gravis: response to long-term immunosuppressive treatment","volume":"62","author":"Sommer","year":"1997","journal-title":"J Neurol Neurosurg Psychiatry"},{"issue":"1","key":"10.1016\/j.ajo.2019.04.017_bib15","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1111\/j.1600-0404.1988.tb06970.x","article-title":"Ocular myasthenia: diagnostic and therapeutic problems","volume":"77","author":"Evoli","year":"1988","journal-title":"Acta Neurol Scand"},{"issue":"3","key":"10.1016\/j.ajo.2019.04.017_bib16","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1002\/mus.21555","article-title":"Ocular myasthenia gravis in a senior population: diagnosis, therapy, and prognosis","volume":"41","author":"Allen","year":"2010","journal-title":"Muscle Nerve"},{"issue":"4","key":"10.1016\/j.ajo.2019.04.017_bib17","doi-asserted-by":"crossref","first-page":"708","DOI":"10.1111\/ene.12057","article-title":"The effect of early prednisolone treatment on the generalization rate in ocular myasthenia gravis","volume":"20","author":"Zach","year":"2013","journal-title":"Eur J Neurol"},{"issue":"7","key":"10.1016\/j.ajo.2019.04.017_bib18","doi-asserted-by":"crossref","first-page":"733","DOI":"10.1001\/archneur.1991.00530190081019","article-title":"Epidemiology of myasthenia gravis in Denmark: a longitudinal and comprehensive population survey","volume":"48","author":"Somnier","year":"1991","journal-title":"Arch Neurol"},{"issue":"5","key":"10.1016\/j.ajo.2019.04.017_bib19","doi-asserted-by":"crossref","first-page":"1233","DOI":"10.1212\/WNL.47.5.1233","article-title":"Epidemiologic evidence for a changing natural history of myasthenia gravis","volume":"47","author":"Phillips","year":"1996","journal-title":"Neurology"},{"issue":"10","key":"10.1016\/j.ajo.2019.04.017_bib20","doi-asserted-by":"crossref","first-page":"1888","DOI":"10.1212\/WNL.42.10.1888","article-title":"The epidemiology of myasthenia gravis in central and western Virginia","volume":"42","author":"Phillips","year":"1992","journal-title":"Neurology"},{"issue":"9","key":"10.1016\/j.ajo.2019.04.017_bib21","doi-asserted-by":"crossref","first-page":"1779","DOI":"10.1212\/WNL.43.9.1779","article-title":"Incidence and prevalence of myasthenia gravis in western Denmark 1975 to 1989","volume":"43","author":"Christensen","year":"1993","journal-title":"Neurology"},{"issue":"4","key":"10.1016\/j.ajo.2019.04.017_bib22","doi-asserted-by":"crossref","first-page":"260","DOI":"10.1111\/j.1600-0404.1996.tb00517.x","article-title":"Myasthenia gravis in the elderly: a hospital based study","volume":"93","author":"Antonini","year":"1996","journal-title":"Acta Neurol Scand"},{"issue":"9","key":"10.1016\/j.ajo.2019.04.017_bib23","doi-asserted-by":"crossref","first-page":"1222","DOI":"10.1002\/(SICI)1097-4598(199909)22:9<1222::AID-MUS8>3.0.CO;2-R","article-title":"Ocular myasthenia gravis: predictive value of single-fiber electromyography","volume":"22","author":"Weinberg","year":"1999","journal-title":"Muscle Nerve"},{"issue":"7","key":"10.1016\/j.ajo.2019.04.017_bib24","doi-asserted-by":"crossref","first-page":"1203","DOI":"10.1016\/S1388-2457(00)00307-2","article-title":"SFEMG in ocular myasthenia gravis diagnosis","volume":"111","author":"Padua","year":"2000","journal-title":"Clin Neurophysiol"},{"issue":"2","key":"10.1016\/j.ajo.2019.04.017_bib25","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1016\/j.jns.2003.08.017","article-title":"The effect of prednisone on the progression from ocular to generalized myasthenia gravis","volume":"217","author":"Monsul","year":"2004","journal-title":"J Neurol Sci"}],"updated-by":[{"DOI":"10.1016\/j.ajo.2020.02.018","type":"erratum","label":"Erratum","source":"publisher","updated":{"date-parts":[[2021,7,1]],"date-time":"2021-07-01T00:00:00Z","timestamp":1625097600000}}],"container-title":["American Journal of Ophthalmology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0002939419301977?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0002939419301977?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,4,23]],"date-time":"2025-04-23T00:56:47Z","timestamp":1745369807000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0002939419301977"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,9]]},"references-count":25,"alternative-id":["S0002939419301977"],"URL":"https:\/\/doi.org\/10.1016\/j.ajo.2019.04.017","relation":{},"ISSN":["0002-9394"],"issn-type":[{"value":"0002-9394","type":"print"}],"subject":[],"published":{"date-parts":[[2019,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Incidence, Epidemiology, and Transformation of Ocular Myasthenia Gravis: A Population-Based Study","name":"articletitle","label":"Article Title"},{"value":"American Journal of Ophthalmology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ajo.2019.04.017","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}